Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Tyratech Inc. currently manages 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This action is assigned to 1 distinct examiner, ISNOR, ALEXANDRA NICOLE. As the busiest examiner for the company, ISNOR, ALEXANDRA NICOLE is responsible for 1 pending office action.
The prosecution is active in 1 distinct art unit. This indicates a specific and concentrated effort within the patent office. With only 1 pending office action, the company's current prosecution profile is minimal. Practitioners should focus on the specific examination style of ISNOR, ALEXANDRA NICOLE, as this 1 examiner and the 1 distinct art unit represent the entirety of the company's current interactions in the Biotechnology & Pharmaceuticals sector. The lack of multiple examiners or art units means there is no internal data to compare examiner behavior or art unit performance for this company. This singular focus requires a high degree of precision in responding to the 1 pending office action to ensure successful portfolio growth.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ISNOR, ALEXANDRA NICOLE | 1 | 26.1% | +26.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18761935 | ARTHROPOD CONTROL COMPOSITIONS AND METHODS | ISNOR, ALEXANDRA NICOLE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18761935 | ARTHROPOD CONTROL COMPOSITIONS AND METHODS | ISNOR, ALEXANDRA NICOLE | — |
| Art Unit | Apps |
|---|---|
| 1611 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18761935 | ARTHROPOD CONTROL COMPOSITIONS AND METHODS | ISNOR, ALEXANDRA NICOLE | 1611 | §103§112 | Non-Final OA | — | Pending | Jul 02, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialTyratech Inc. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Alexandra Nicole Isnor has the most, with 1 of Tyratech Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
